Advertisement

International Journal of Clinical Pharmacy

, Volume 37, Issue 3, pp 546–547 | Cite as

Erratum to: Comparison of the prevalence of convulsions associated with the use of cefepime and meropenem

  • Akihiro TanakaEmail author
  • Kenshi Takechi
  • Shinichi Watanabe
  • Mamoru Tanaka
  • Katsuya Suemaru
  • Hiroaki Araki
Erratum
  • 1.1k Downloads

Erratum to: Int J Clin Pharm (2013) 35:683–687 DOI 10.1007/s11096-013-9799-3

In the original publication, an incorrect Table 2 (Table 1 duplicated) has been published inadvertently. The correct Table 2 is given in this erratum.
Table 2

Clinical characteristics of patients with meropenem-associated convulsions

No.

Patient characteristics

(sex, age, eGFR)

Daily dosing schedule

Time of symptoms

(days from start of cefepime)

Symptoms and signs

Baseline disease

Anticonvulsant agent

Final assessment

A

F, 42,

95 mL/min

0.5 g every 8 h

2

Clonic convulsion

Cerebral infarction

Phenytoin (iv), valproic acid (po)

Administer thiamylal, and then complete resolution

B

M, 59,

106 mL/min

0.5 g every 8 h

2

Clonic convulsion

Encephaloma

None

Administer diazepam intravenously, and then complete resolution

C

F, 74,

69 mL/min

1 g every 12 h

2

Myoclonus

Multiple cerebral infarction

Clonazepam (po)

Administer diazepam intravenously, but uncontrollable convulsion, and then complete resolution

D

F, 39,

76 mL/min

1 g every 12 h

2

Clonic convulsion and decreased level of consciousness

B- cell lymphoma

(infiltration brain), febrile neutropenia

Zonisamide (po)

Administer diazepam intravenously, and then complete resolution after the discontinuation of meropenem

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2015

Authors and Affiliations

  • Akihiro Tanaka
    • 1
    Email author
  • Kenshi Takechi
    • 1
  • Shinichi Watanabe
    • 1
  • Mamoru Tanaka
    • 1
  • Katsuya Suemaru
    • 2
  • Hiroaki Araki
    • 1
  1. 1.Division of PharmacyEhime University HospitalToon, EhimeJapan
  2. 2.School of PharmacyShujitu UniversityOkayamaJapan

Personalised recommendations